PermaNet® 3.0 - Combination Net

The World Health Organization (WHO) estimates an annual occurrence of 255 million cases of malaria worldwide. The toll is the highest in developing countries where at least 655,000 people die from the disease. Young children account for most of these deaths.

Moreover, malaria is a great burden on many national economies. Many economists believe that malaria is responsible for a 'growth penalty' of up to 1.3% of GDP per year in some countries. Since the disease is widely prevalent in the least developed countries, this leads to a vicious cycle of disease and poverty.

The PermaNet^® technology, developed by Vestergaard Frandsen, combats malaria with the use of insecticide-treated bednets. This superior technology controls the slow release and migration of the WHO-approved insecticide in the yarn to the surface of the netting, resulting in long-lasting efficacy even after multiple washes.

Insecticide resistance is emerging as a serious public health crisis. Pyrethroid resistant malaria vectors are able to overcome the effects of the insecticide through physiological changes. New approaches are required to address this growing challenge.

Superior PermaNet^® 3.0 technology uses the synergist ‘piperonyl butoxide’ to increase the bioefficacy of the pyrethroid deltamethrin. Laboratory and field evidence indicates that PermaNet^® 3.0 has increased efficacy against pyrethroid-resistant* malaria vectors. Vestergaard Frandsen is committed to investing in products that will protect the most vulnerable members of society.

*as tested with oxidase, esterase and kdr resistant malaria vectors